Assessment of sleep in children with mucopolysaccharidosis type III

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Mahon, Louise Victoria ^a   Lomax, Michelle ^a   Grant, Sheena ^a   Cross, Elaine ^a   Hare, Dougal Julian ^a   Wraith, James Ed ^b   Jones, Simon ^b   Bigger, Brian ^c   Langford Smith, Kia ^c   Canal, Maria ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ACTIMETRY; ADOLESCENT; ARTICLE; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LATENT PERIOD; MALE; QUESTIONNAIRE; SALIVA ANALYSIS; SANFILIPPO SYNDROME; SLEEP; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; CASE CONTROL STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; TIME;

ACTIGRAPHY; ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MELATONIN; MUCOPOLYSACCHARIDOSIS III; SLEEP; TIME FACTORS;

EID: 84896882213     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084128     Document Type: Article

References (35)

1. Heron B, Mikaeloff Y, Froissart R, Caridade G, Maire I, et al. (2011) Incidence and natural history of Mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 155A: 58-68.
2. Meyer A, Kossow K, Gal A, Muehlhausen C, Ullrich K, et al. (2007) Scoring evaluation of the natural course of Mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 120: e1255-61. (Pubitemid 350085522)
3. Cleary MA, Wraith JE (1993) Management of Mucopolysaccharidosis type-III. Arch Dis Child 69: 403-406.
4. Van De Kamp JJP, Niermeijer MF, Von Figura K, Giesberts MAH (1981) Genetic heterogeneity and clinical variability in the Sanfilippo syndrome types A B and C. Clin Genet 20: 152-160. (Pubitemid 11027917)
5. Ruijter GJG, Valstar MJ, de Kamp JM, van der Helm RM, Durand S, et al. (2008) Clinical and genetic spectrum of Sanfilippo type c (MPS IIIC) disease in the Netherlands. Mol Genet Metab 93: 104-111.
6. Valstar MJ, Ruijter GJG, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: A mini-review. J Inherit Metab Dis 31: 240-252.
7. Bax MCO, Colville GA (1995) Behaviour in Mucopolysaccharide disorders. Arch Dis Child 73: 77-81.
8. Colville GA, Watters JP, Yule W, Bax M (1996) Sleep problems in children with Sanfilippo syndrome. Dev Med Child Neurol 38: 538-544. (Pubitemid 26225955)
9. Cross E (2012) An investigation into the middle and late behavioural phenotypes of Mucopolysaccharidosis type-III (Unpublished doctoral dissertation). University of Manchester, Manchester, UK.
10. Fraser J, Gason AA, Wraith JE, Delatycki MB (2005) Sleep disturbance in Sanfilippo syndrome: A parental questionnaire study. Arch Dis Child 90: 1239-1242. (Pubitemid 41736308)
11. Fraser J, Wraith JE, Delatycki MB (2002) Sleep disturbance in Mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians. Clin Genet 62: 418-421. (Pubitemid 36372768)
12. Mariotti P, Della Marca G, Iuvone L, Vernacotola S, Ricci R, et al. (2003) Sleep disorders in Sanfilippo syndrome: A polygraphic study. Clin Electroencephalogr 34: 18-22. (Pubitemid 36014965)
13. Tikotzky L, Sadeh A (2001) Sleep patterns and sleep disruptions in kindergarten children. J Clin Child Psychol 30: 581-591. (Pubitemid 33658645)
14. Jean-Louis G, Kripke DF, Mason WJ, Elliott JA, Youngstedt SD (2001) Sleep estimation from wrist movement quantified by different actigraphic modalities. J Neurosci Methods 105: 185-191. (Pubitemid 32223939)
15. De Leersnyder H, Claustrat B, Munnich A, Verloes A (2006) Circadian rhythm disorder in a rare disease: Smith-Magenis syndrome. Mol Cell Endocrinol 252: 88-91.
16. De Leersnyder H, De Blois MC, Claustrat B, Romana S, Albrecht U, et al. (2001) Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr 139: 111-116. (Pubitemid 32613996)
17. Guerrero JM, Pozo D, Diaz-Rodriguez JL, Martinez-Cruz F, Vela-Campos F (2006) Impairment of the melatonin rhythm in children with Sanfilippo syndrome. J Pineal Res 40: 192-193.
18. Canal MM, Wilkinson FL, Cooper JD, Wraith JE, Wynn R, et al. (2010) Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of Mucopolysaccharidosis IIIB. Behav Brain Res 209: 212-220.
19. Langford-Smith K, Arasaradnam M, Wraith JE, Wynn R, Bigger BW (2010) Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from Mucopolysaccharidosis I, IIIA and IIIB mice. Mol Genet Metab 99: 269-274.
20. Langford-Smith KJ, Mercer J, Petty J, Tylee K, Church H, et al. (2011) Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in Mucopolysaccharide diseases. J Inherit Metab Dis 34: 499-508.
21. Samel A, Wegmann HM, Vejvoda M, Maass H, Gundel A, et al. (1991) Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hr time shift. J Biol Rhythms 6: 235-248.
22. Owens JA, Spirito A, McGuinn M (2000) The Children's Sleep Habits Questionnaire (CSHQ): Psychometric properties of a survey instrument for school-aged children. Sleep 23: 1043-1051. (Pubitemid 32046173)
23. Acebo C, Sadeh A, Seifer R, Tzischinsky O, Wolfson AR, et al. (1999) Estimating sleep patterns with activity monitoring in children and adolescents: How many nights are necessary for reliable measures? Sleep 22: 95-103. (Pubitemid 29097903)
24. Galland BC, Taylor BJ, Elder DE, Herbison P (2012) Normal sleep patterns in infants and children: A systematic review of observational studies. Sleep Med Rev 16: 213-222.
25. Paavonen EJ, Fjallberg M, Steenari MR, Aronen ET (2002) Actigraph placement and sleep estimation in children. Sleep 25: 235-237. (Pubitemid 34193586)
26. Stores G, Montgomery P, Wiggs L (2006) The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics 118: E1116-E1123. (Pubitemid 46393760)
27. El-Sheikh M, Buckhalt JA, Keller PS, Granger DA (2008) Children's objective and subjective sleep disruptions: Links with afternoon cortisol levels. Health Psychol 27: 26-33. (Pubitemid 351215344)
28. Scholle S, Beyer U, Bernhard M, Eichholz S, Erler T, et al. (2011) Normative values of polysomnographic parameters in childhood and adolescence: Quantitative sleep parameters. Sleep Med 12: 542-549.
29. Lin HY, Chen MR, Lin CC, Chen CP, Lin DS, et al. (2010) Polysomnographic characteristics in patients with Mucopolysaccharidoses. Pediatr Pulmonol 45: 1205-1212.
30. Santamaria F, Andreucci MV, Parenti G, Polverino M, Viggiano D, et al. (2007) Upper airway obstructive disease in Mucopolysaccharidoses: Polysomnography, computed tomography and nasal endoscopy findings. J Inherit Metab Dis 30: 743-749. (Pubitemid 47559887)
31. Phillips L, Appleton RE (2004) Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol 46: 771-775. (Pubitemid 39468026)
32. Jan JE, Hamilton D, Seward N, Fast DK, Freeman RD, et al. (2000) Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res 29: 34-39. (Pubitemid 30449699)
33. Stores G (2003) Medication for sleep-wake disorders. Arch Dis Child 88: 899-903.
34. Sheldon SH (1998) Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 351: 1254-1254.
35. de Ruijter J, Valstar MJ, Wijburg FA (2011) Mucopolysaccharidosis type III (sanfilippo syndrome): Emerging treatment strategies. Curr Pharm Biotechnol 12: 923-930.